Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Cyclarity Therapeutics

Request full access
Novato, United StatesFounded 2019Biotech & Life Sciences

About Cyclarity Therapeutics

Underdog Pharmaceuticals, now rebranded as Cyclarity Therapeutics, is a biopharmaceutical company that operates in the healthcare sector. The company is primarily focused on developing innovative treatments for age-related diseases, with a particular emphasis on atherosclerosis, a condition characterized by the hardening and narrowing of the arteries.

Cyclarity's unique approach involves targeting toxic forms of cholesterol with specially designed molecules. This method aims to not just manage the symptoms of diseases like atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration, but to modify the disease itself, potentially reversing its effects. This is a significant departure from traditional treatments, which typically focus on managing symptoms rather than addressing the root cause of the disease.

The company's primary clients are patients suffering from these age-related diseases. By offering a potential cure rather than just symptom management, Cyclarity has the potential to disrupt the healthcare market significantly.

Cyclarity's business model is based on the research, development, and commercialization of its disease-modifying treatments. The company makes money by selling these treatments to healthcare providers, who then administer them to patients.

In summary, Cyclarity Therapeutics is a forward-thinking biopharmaceutical company that aims to revolutionize the treatment of age-related diseases by targeting their root causes rather than just managing symptoms.

Source: Dealroom company data

At a glance

Status
Operational
Employees
21
Open positions
None listed
Dealroom signal
82.2/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Cardiology and cardiovascular, Spinout, Biotech and Pharma, DT and LS, science-based
Client focus
B2B

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SEED✓Equity / VC Sep 2021 $10M $40M Kizoo —
SPINOUT✓Other financing Nov 2019 $0 — SENS Research Foundation —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Cyclarity Therapeutics website traffic

Latest recorded traffic for Cyclarity Therapeutics is 2.2K monthly website visits, down 45% over the last three months. Cyclarity Therapeutics's team grew 31.3% over the past year.

Latest monthly visits2.2K 3-month web change-45% 1-year team growth+31.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Cyclarity Therapeutics in the Novato ecosystem

Live from Dealroom

The Cyclarity Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

Other known investors4 additional known investors

Team profiled 8 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
4 countries with
team presence
🇺🇸 United States78.6%
🏳️ Mauritius7.1%
🇨🇦 Canada7.1%
🇳🇱 Netherlands7.1%
4 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Cyclarity Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Cyclarity Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.